Ariff Abdul Shatar said earnings in the upcoming quarters will be buoyed by the RM375mil revised

PETALING JAYA: Duopharma Biotech Bhd posted a 4.5% year-on-year( y-o-y) growth in net profit to RM15. 4mil while revenue grew 8.45% to RM155. 4mil for its second quarter ended June 30, 2021, supported by higher sales to the consumer healthcare and public health sector. For the first half, net profit grew 16.7% y-o-y to RM33mil while revenue was 6.6% higher to RM321. 9mil.... The group has declared a first interim single-tier dividend of 0.5 sen per share.“ We are cautiously optimistic about our

KUALA LUMPUR: Duopharma Biotech Bhd’s net profit rose 20% to RM16. 96mil in the third quarter ended Sept 30, from RM14. 12mil a year ago. The improved performance was mainly due to higher demand from consumer healthcare and the public health sector. Its revenue for the quarter stood at RM171. 83mil, up 28.45% from RM133. 77mil. Cumulatively, net profit jumped 18% in the first nine months this year to RM49. 97mil, on the back of a 13% increase in revenue totalling RM493. 73mil. Duopharma group ma

Almost all sectors are expected to open by then. Despite the fact that Malaysia will soon reopen, the life people will return to will not be the same as the one they left before Covid-19 came into the scene.... Companies planning to reopen their offices are required to make changes to ensure good ventilation and prevent transmission of Covid-19 in the workplace.In the meantime, they have also invested in infrastructure that allows eligible employees to work remotely during lockdowns.... With C